Format

Send to

Choose Destination
Interv Neurol. 2015 Oct;4(1-2):5-17. doi: 10.1159/000438773. Epub 2015 Sep 18.

Innovative Interventional and Imaging Registries: Precision Medicine in Cerebrovascular Disorders.

Author information

1
Neurovascular Imaging Research Core, University of California, Los Angeles, and Comprehensive Stroke Center and Department of Neurology, Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, Calif., USA.

Abstract

BACKGROUND:

Precision medicine in cerebrovascular disorders may be greatly advanced by the use of innovative interventional and imaging-intensive registries. Registries have remained subsidiary to randomized controlled trials, yet vast opportunities exist to leverage big data in stroke.

SUMMARY:

This overview builds upon the rationale for innovative, imaging-intensive interventional registries as a pivotal step in realizing precision medicine for several cerebrovascular disorders. Such enhanced registries may serve as a model for expansion of our translational research pipeline to fully leverage the role of phase IV investigations. The scope and role of registries in precision medicine are considered, followed by a review on the history of stroke and interventional registries, data considerations, critiques or barriers to such initiatives, and the potential modernization of registry methods into efficient, searchable, imaging-intensive resources that simultaneously offer clinical, research and educational added value.

KEY MESSAGES:

Recent advances in technology, informatics and endovascular stroke therapies converge to provide an exceptional opportunity for registries to catapult further progress. There is now a tremendous opportunity to deploy registries in acute stroke, intracranial atherosclerotic disease and carotid disease where other clinical trials leave questions unanswered. Unlike prior registries, imaging-intensive and modernized methods may leverage current technological capabilities around the world to efficiently address key objectives and provide added clinical, research and educational value.

KEYWORDS:

Atherosclerosis; Endovascular therapy; Imaging; Precision medicine; Registry; Stroke

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland Icon for PubMed Central
Loading ...
Support Center